Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 91
Selected: 0
NCT IDTitle
NCT02033317An Open-Label, Multiple Dose Study to Evaluate the Pharmacology, Safety, and Tolerability of Patiromer in Participants on Hemodialysis
NCT02937454Study to Compare Ferric Carboxymaltose With Placebo in Patients With Acute Heart Failure and Iron Deficiency
NCT03759964Effects of Ferinject® on Anemia and Transfusion Rates After Cardiac Surgery
NCT02243735Trial Comparing Ferric(III)Carboxymaltose Infusion With Oral Iron Suppletion as Treatment of Anaemia
NCT06434025IV Iron and SGLT2 Inhibitor on Ventricular Function and Myocardial Iron Content in Heart Failure With Iron Deficiency
NCT00994318Ferric Carboxymaltose (FCM) Assessment in Subjects With Iron Deficiency Anaemia and Non-dialysis-dependent Chronic Kidney Disease (NDD-CKD)
NCT05897684Avacostar - (PASS)
NCT01394562Effect of Ferric Carboxymaltose on Exercise Capacity in Patients With Iron Deficiency and Chronic Heart Failure
NCT04817670Study to Assess Efficacy and Safety of VIT-2763 (Vamifeport) in Subjects With Sickle Cell Disease
NCT01371747Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)
NCT05625542Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Hemodialysis Patients
NCT01477411A Drug-Drug Interaction Study of Digoxin and PA21
NCT01245777Restless Legs Syndrome With Iron Deficiency or Anaemia in the 3rd Trimester of Pregnancy
NCT02221752Impact of Iron/Folic Acid vs Folic Acid Supplements During Pregnancy on Maternal and Child Health
NCT05885737Phase 3 Study of Difelikefalin in Haemodialysis Chinese Adult Subjects With Moderate-to-Severe Pruritus
NCT04903717Pragmatic Trial Of Alerts for Use of Mineralocorticoid Receptor Antagonists
NCT01438359A Drug-Drug Interaction Study of Furosemide and PA21
NCT01820949Safety and Effectiveness of a Patient Blood Management (PBM) Program in Surgical Patients
NCT02213653Randomized Study Evaluating Agents Stimulants Erythropoiesis (ASE) Associated With Ferric Carboxymaltose (Ferinject ®) in Concomitant or Sequential Patients Treated for Cancer and With Anemia Associated With Functional Iron Deficiency
NCT05524467Cross-sectional Study to Assess Prevalence and Burden of CKD-associated Pruritus in Haemodialysis Patients
NCT06593392Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus
NCT00706667Intravenous Ferric Carboxymaltose (Ferinject®) With or Without Erythropoietin in Patients Undergoing Orthopaedic Surgery
NCT01464190A Phase 3 Extension Study to Investigate the Long-term Safety, Tolerability and Efficacy of PA21, a Phosphate Binder in Dialysis Patients
NCT05415969CKD-aP Among Adults on Dialysis in Switzerland
NCT04510792IMpact of hyPeRkalaemia on thErapy With Renin angiotenSin aldoSterone System Inhibitors
NCT00520780Ferinject® Assessment in Patients With Iron Deficiency and Chronic Heart Failure (FAIR-HF)
NCT04616092Effect of Preoperative Intravenous Ferric Carboxymaltose for Clipping Surgery
NCT03010072The Effect of Phosphate Lowering Using Sucroferric Oxyhydroxide (PA21) on Calcification Propensity of Serum
NCT03888066Patiromer for the Management of Hyperkalemia in Subjects Receiving RAASi Medications for the Treatment of Heart Failure (DIAMOND)
NCT02687594Non-interventional Study to Investigate the Short and Long Term Real-life Safety, Effectiveness, and Adherence of Velphoro® in Patients With Hyperphosphataemia Undergoing Haemodialysis (HD) or Peritoneal Dialysis (PD)
NCT00882414Ferinject® in Patient With Thrombocytosis Secondary to Inflammatory Bowel Disease (IBD)
NCT00414128Clinical Trial of Mycophenolate Versus Cyclophosphamide in ANCA Vasculitis
NCT01452906A Drug-Drug Interaction Study of Omeprazole and PA21
NCT02846896The Health Burden of Primary Biliary Cirrhosis (PBC) in Switzerland
NCT05885763Pharmacokinetics of Intravenous Difelikefalin in Chinese Adult Subjects on Haemodialysis
NCT04364269Safety, Tolerability, Pharmacokinetics (PK), Pharmacodynamics (PD) and Preliminary Efficacy of VIT-2763 in β-thalassaemia
NCT03214627Artificial Intelligence for Optimal Anemia Management in End-stage Renal Disease: The Anemia Control Model (ACM) Trial
NCT00810030FERINJECT for Correction of Anaemia in IBD Patients, FER-IBD-COR
NCT05766839Patiromer for Treatment of Hyperkalaemia in Children Under 12 Years of Age
NCT02125344A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto)
NCT03591406To Assess the Impact of Ferric Carboxymaltose Compared With Iron Sucrose in Chinese Subjects on Correcting Iron Deficiency Anaemia
NCT01975272The Use of Iron Therapy for Patients With Anemia After Caesarean Section
NCT00978575Iron Substitution After Upper Gastro-Intestinal Bleeding
NCT03047954Broncho-Vaxom (OM 85 BV) in Children Suffering From Atopic Dermatitis
NCT01324752A Drug-Drug Interaction Study of Losartan and PA21
NCT05389826mHealth for Phosphorus Management in CKD.
NCT01345968Intravenous Ferric Carboxymaltose (Ferinject) in Patients Undergoing Orthopaedic Surgery
NCT03781089Patiromer Efficacy to Reduce Episodic Hyperkalemia in End Stage Renal Disease Patients
NCT01453608A Study to Compare the Use of Ferric Carboxymaltose With Placebo in Patients With Chronic Heart Failure and Iron Deficiency
NCT05751772Improving Knowledge in Heart Failure Inpatient With Therapeutic Education